ArticleMalaria journal2025
Utilization of insecticide-treated bed nets and key factors among households in resource-limited settings, Northwest Ethiopia.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Acceptability of insecticide treated nets in an urban setting in a malarious area: Application of theoretical framework of acceptability.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInsecticide-treated mosquito nets (ITNs) act as an essential tool in malaria prevention by serving as a physical barrier against the disease. In sub-Saharan Africa, the use of ITNs remains a cornerstone in efforts to reduce malaria transmission. Despite their importance, there is limited evidence on ITN utilization and the factors influencing their use in Ethiopia. The objective of this study was to assess utilization of insecticidal treated bed nets and its key factors among Households in resource-limited settings, Northwest, Ethiopia, in 2024.
methodsA community-based cross-sectional study was carried out from January 30 to March, 2024. A total of 492 randomly selected Households were included. Data were acquired using a pre-tested structured questionnaire and an observational checklist. Binary logistic regression was initially used to select variables associated with the use of insecticide-treated bed nets. Variables with a p-value less than 0.25 in the bivariable analysis were selected for inclusion in the multivariable logistic regression model. In the multivariable analysis, factors with a p-value less than 0.05 and 95% confidence intervals were considered statistically significant.
resultsA total of 492 study participants responded to the questionnaire, resulting in a response rate of 98.4%. Approximately 71.3% (95% CI 67.2%, 74.9%) of the respondents reported utilizing insecticide-treated nets on the night before the data collection day. Factors significantly associated with ITN utilization included being female (AOR = 1.538; 95% CI 1.157, 3.135), households with illiterate educational status (AOR = 0.237; 95% CI 0.026, 0.871), households with monthly income > 1000 ETB (AOR = 1.372; 95% CI 1.038, 3.184), and households that had received information (messages) about ITN use (AOR = 1.310; 95% CI 1.125, 3.229).
conclusionThe utilization of insecticide-treated bed nets (ITNs) among households was 71.3%, which was lower than the WHO recommendation (80%). Key factors significantly associated with ITN utilization included being female, educational status, higher household income, and receiving information (messages) about ITN use. Targeted interventions, such as community education and awareness campaigns, are essential to improve ITN utilization. Addressing these factors can close the gap with WHO standards and reduce the malaria burden effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.